5a-Androstane-3a,17b-diol (3a-diol) is considered to have no androgenic effects in androgen target organs unless it is oxidized to 5a-dihydrotestosterone (5a-DHT). We used microarray and bioinformatics to identify and compare 3a-diol and 5a-DHT responsive gene in human prostate LNCaP cells. Through a procedure called 'hypervariable determination', a similar set of 30 responsive genes involving signal transduction, transcription regulation, and cell proliferation were selected in 5a-DHT-, 3a-diol-, and epidermal growth factor (EGF)-treated samples. F-means cluster and networking procedures showed that the responsive pattern of these genes was more closely related between 3a-diol and EGF than between 5a-DHT and 3a-diol treatments. We conclude that 3a-diol is capable of stimulating prostate cell proliferation by eliciting EGF-like pathway in conjunction with androgen receptor pathway.
Introduction
Androgens are responsible for development, growth, differentiation, and function of the prostate. 5a-Dihydrotestosterone (5a-DHT), the most potent androgen in the prostate with high affinity toward the androgen receptor (AR; K d ¼ 10 À10 M), 1 modulates androgen responsive gene (ARG) expression, 2, 3 and has been implicated in the development of prostatic diseases including benign prostatic hyperplasia (BPH) and prostate cancer (PCa). 4 Within the prostate, 5a-DHT can be reduced to weaker androgens, including 5a-androstane-3a,17b-diol (3a-diol) and 5a-androstane3b,17b-diol (3b-diol), through the action of 3a-hydroxysteroid dehydrogenase (3a-HSD) and 3b-HSD, respectively. Of these two pathways, prostatic 3a-HSDs play dominant roles in 5a-DHT reduction. 5, 6 3a-Diol has a low binding affinity toward the AR with K d ¼ 10 À6 M, 7 and it is believed that 3a-diol must first be oxidized to 5a-DHT by 3a-HSD, 8 retinol dehydrogenase (RoDH), 9 11-cis-retinol dehydrogenase (RDH5), 10 or mitochondrial L-3-hydroxyacyl coenzyme A dehydrogenase (ERAB, 17b-HSD type 10) 11 before exerting its androgenic effects. However, increasing evidence suggests that 3a-diol may be an important androgen in the induction of prostatic hyperplasia through yet undefined pathways, 12 including cAMP, 13 in a castrated dog model, 8, 14, 15 in virilizing rat urogenital tract, 16 and in prostate formation in marsupial animals. 17 We have shown that 3a-diol can stimulate similar levels of cell proliferation without eliciting comparable AR transactivation activities as compared to those of 5a-DHT in human PCa LNCaP cells. 18 Furthermore, 3a-diolregulated gene expression can be distinguished from 5a-DHT responsive genes in prostate cells. These results suggest that 3a-diol may activate pathways other than classical AR trans-activation to stimulate prostate cell proliferation. 18 Expression of epidermal growth factor (EGF) has been demonstrated in epithelial cells of normal and diseased prostate. 19, 20 EGF exerts a mitogenic effect on human prostate epithelium in vitro. 21, 22 EGF also induces AR trans-activation in the absence of androgen. 23 Although it is widely suspected that EGF-and EGF receptor (EGFR)-activated signaling pathways may play a major role in the progression from androgen-dependent to androgenindependent PCa, complex interactions between androgens and EGF remain unclear in the prostate gland.
In this study, we used cDNA-based microarrays to further refine our understanding of the temporal regulation of gene expression in LNCaP cells in response to 5a-DHT, 3a-diol, and EGF stimulation. Based on bioinformatics analysis of similarities and connectivity of commonly expressed genes in LNCaP cells exposed to androgens and EGF, our results showed that associations of 3a-diol responsive genes bear a closer resemblance to the EGF responsive patterns than those in response to 5a-DHT stimulation. Our results also suggested that 3a-diol may also exert its androgenic effects via a pathway similar to growth factor pathway in LNCaP cells.
Materials and methods
Reagents and chemicals LNCaP human PCa cell line was obtained from American Type Culture Collection (ATCC # CRL-1740). 5a-DHT and 3a-diol were purchased from Sigma-Aldrich (St Louis, MO, USA). [a- 32 P]dATP (3000 Ci/mmol, 10 mCi/ml) was acquired from Amersham Pharmacia (Piscataway, NJ, USA). RPMI 1640 medium, OPTI-MEM, penicillin-streptomycin, and EGF were purchased from Invitrogen (Carlsbad, CA, USA). Fetal bovine serum (FBS) was acquired from Atlanta Biologicals (Norcross, GA, USA). Charcoal-dextrantreated (CD) FBS was obtained from HyClone (Logan, UT, USA). Atlas Human 1.2 Array and Atlas Human Cancer 1.2 Array were obtained from BD Biosciences Clontech (Palo Alto, CA, USA).
Cell culture
LNCaP cells were maintained at 371C and 5% CO 2 in RPMI 1640 medium supplemented with 10% FBS, 5 U/ml penicillin, and 5 mg/ml streptomycin. Cells were passaged every 3-5 days or whenever cells reach 70-80% confluence.
Cell proliferation assay LNCaP cell proliferation in response to androgens and EGF stimulation was determined as previously described. 18 Briefly, 2 Â 10 3 cells in RPMI 1640 containing 10% FBS were seeded in each well of 96-well plates for adherence followed by serum deprivation and 5a-DHT (10
À11
-10 À8 M), or EGF (0.1-10 ng/ml) stimulation. Control wells did not receive the androgens or EGF. Cell number was determined using an XTT cell proliferation kit (Roche, Indianapolis, IN, USA). Results were normalized to day 0 and are presented as fold induction after treatment. cDNA-based membrane array hybridization To identify transcription profiling in LNCaP cells following androgens and EGF stimulation, cDNA-based membrane arrays were used as previously reported. 18 Briefly, between 0 and 48 h after stimulation, total RNA was extracted from LNCaP cells treated with 10 À12 M 5a-DHT, 10 À11 M 3a-diol, or 1 ng/ml EGF using Trizol (Invitrogen). Equal amounts of total RNA were pooled from three repeats for each time point. Radiolabeled probes were prepared from reverse transcription using 5 mg of the pooled total RNA from each time point in the presence of gene-specific CDS primers (Clontech), dNTPs, 35 mCi [a-32 P]dATP, and 200 U Superscript II reverse transcriptase (Invitrogen) in a total of 10 ml at 421C for 1 h. The radiolabeled cDNAs were purified, and radioactivity was determined with LS 6000IC scintillation counter (Beckman Coulter).
Array membrane hybridization and washing steps also followed procedures described by Nunlist et al.
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Washed membranes were then exposed to phosphorimaging screens, and images were captured through the Cyclone storage phosphoimager system (Packard BioScience) and interpreted using OptiQuant image analysis software (Packard BioScience). For a complete list of genes present in these arrays, see http:// www.clontech.com/atlas/genelists/index.html.
Microarray data analysis procedure
Normalization Gene expression profiles among different experiments were normalized to their background and adjusted to each other using the procedure described in detail elsewhere. 24 In brief, the procedure assumed that signals (S) from nonexpressed genes were normally distributed. The mean (S 0 ) and standard deviation (SD 0 ) of these nonexpressed genes were calculated using an iterative nonlinear curve fitting procedure and used as background parameters for normalization using the formula S 0 ¼ (SÀS 0 )/SD 0 . After normalization, 'expressed' genes were selected as genes not associated with a representative homogenous family of background level values and used for subsequent profile adjustment and comparison.
We performed normalization between arrays for genes expressed above background by robust regression analysis. Potential outliers were identified, and their contributions to the calculations were downweighted in an iterative manner in order to diminish their influences. Expression profiles of control and experimental groups were then rescaled to a common standard: the averaged profile of the control group.
A group of similarly expressed genes from control experiments, denoted 'reference group', was identified and used for selection of variable genes and F-clustering procedure (below). The reference group consisted of genes from the control samples whose expression levels were above the background level in at least one time point and had very low variability as determined by Selection of hypervariable (HV) genes Genes expressed above background in at least one time point were tested for the high variability as described in detail elsewhere. [24] [25] [26] Briefly, residuals were calculated as expressions in each time point minus their average over time course for identified genes. Standard deviation (s.d.) of the residuals of each gene was compared with s.d. of reference group by F-test with threshold adjusted to p ¼ 1/N, where N is the number of expressed genes. The HV genes were selected as having low probability to belong to the family of stable genes of the reference group, po1/N, and were used for F-means clustering. 25 
F-means clustering analysis of gene expression dynamics
Genes with expression above background in at least one time point in any of the three treatments were selected as HV genes and used in clustering. To avoid the influence of low-intensity genes whose expression was presented by large negative values in logarithmic coordinates, their expressions were substituted by random values within 0-0.1 ranges. We estimated the proximity of the genes' profiles over time course by calculating their deviations from each other in each time point and comparing the s.d. of these deviations with internal standard of stability (s.d. of the residuals of the reference group). We determined a parameter (termed 'connectivity') for each of these HV genes. Connectivity was defined as the number of genes whose dynamic behavior of expression during the time course varied from the expression pattern of a given gene within ranges of the reference group (based on an F criterion). A 0.0005 threshold for the F-test was used to diminish the portion of falsepositive selections.
HV genes of the control group were sorted by their connectivity and the clustering process was started with genes of higher connectivity. Genes of the highest connectivity were used as the seed for the first cluster, and all genes with connection to this seed composed cluster 1. Among the genes not belonging to the first cluster, the gene of the highest connection became the seed of the second cluster and all genes connected to it composed the second cluster. This process was repeated recursively until the last gene had been clustered. This method was developed to maximize the size of the clusters so that comprehensive global group dynamics could be revealed. In this statistical model, genes appearing in more than one cluster were likely to be functional links among these clusters, and genes with zero connectivity were dissimilar from any other gene.
To find common expression patterns between different experiments, data from all three treatments were grouped for clustering analysis and then segregated for further analysis. An identical cluster designation in all three treatments indicated similar dynamic behavior. Genes of the same clusters were then sorted by their connectivity. Matrices of correlation coefficients were calculated for genes in a pairwise fashion and presented as a graphical correlation mosaic output 26, 27 showing patterns of correlated and noncorrelated behavior of genes for visual inspection. Genes were presented in the same order in all three figures, and changes in color indicated expression variation between different treatments.
Networking of the genes based on partial correlation coefficients Correlation coefficients can be used as a measure of gene coexpression within clusters; however, not every pair of highly correlated genes are functionally interconnected. Rather, they could be under a common influence of separate genes (such as common regulatory). The partial correlation coefficient with excluded influences from other genes is a better characteristic of the functional interconnection. 28 To elicit a casual inference of genes, we used a procedure (described in detail elsewhere 26 ) applying a partial correlation coefficient. The partial correlation of variables x and y with respect to z was defined as an x-y correlation after removing the effects of z or pr xy,z ¼ (r xy Àr xz r yz )/((1Àr xz 2 )(1Àr
. This analysis was performed in a pairwise manner for all genes shown to be related by cluster analysis. A program written in Matlab (MathWorks Inc.) was used to calculate the partial correlation for each element of a group of genes whose intercorrelation was above the threshold of t1. Results were presented in a square matrix. For gene a, each element of the matrix Xij is the partial correlation of a with gene i without the influence of gene j. Genes whose correlation did not change below the thresholds t2 without the influence of a third gene were considered to be truly connected. The thresholds t1 and t2 used to determine the significant interconnections were calculated from a Monte Carlo simulation on data of the same mean and s.d. as the experimental data to exclude random connections. This refinement of assessing gene inter-relationships provides a means of identifying genes that were likely to be directly related, and, therefore, functionally related, as opposed to cluster and correlation analysis, which identifies genes that are simply correlated in their behavior.
RT-PCR Total RNA was extracted from these 5a-DHT-
, or EGF-(1 ng/ml) treated LNCaP cells using Trizol (Invitrogen), and first-strand cDNAs were reverse transcribed from 2.5 mg of the total RNA in the presence of random hexamers (Roche), 20 mM each of dNTPs, and 200 U of MMLV reverse transcriptase (Invitrogen) in a total of 50 ml at 421C for 2 h. QPCR reactions were performed by mixing 1 ml of first-strand cDNAs, gene-specific 5 0 and 3 0 primers (Table 1) , and 15 ml of QuantiTectt SYBR s Green PCR kit (QIAGEN) in a total of 30 ml. Reactions were performed by heat activation at 941C for 15 min, followed by cycling through 941C for 30 s, 50-551C for 1 min, and 721C for 1 min in iCycler (Bio-Rad) for a total of 40 cycles. All PCR reactions were run in duplicate and repeated at least three times. The amplified products were quantified using the threshold value (C T ), which is associated with the exponential growth of the PCR products for each gene product calculated by the BioRad iCycler iQ system program (Bio-Rad). No template controls in which no RNA samples were reverse transcribed failed to produce C T values at least three cycles higher than those reversely 3a-diol regulated gene expression in LNCaP cells RA Zimmerman et al transcribed samples. Melting point analysis was performed to ensure that single species of PCR product was generated in each reaction. b-Actin was also amplified and used for normalization. Results were calculated as DC T , the difference between the gene of interest and the b-actin gene mean thresholds, and expressed as expression levels relative to b-actin.
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Results
Stimulation of human prostate cancer LNCaP cell proliferation by androgens and EGF
We have previously shown a similar level of LNCaP cell proliferation when cells were treated with 10 À12 M 5a-DHT and 10 À11 M 3a-diol. However, 5a-DHT is a more potent androgen in activating AR trans-activation activity. EGF (0.1-10 ng/ml) also has similar mitogenic efficiency in stimulating LNCaP cell proliferation. Over a period of 6 days, the concentrations used to treat LNCaP cells for identification and comparison of responsive genes among androgens and EGF stimulated a similar level of cell proliferation (Figure 1 ).
Identification of genes regulated by androgens and EGF treatment using associative analysis
To identify genes that respond to androgens and EGF stimulation, LNCaP cells were treated with 10 À12 M 5a-DHT, 10 À11 M 3a-diol, or 1 ng/ml EGF in serum-deficient medium. Changes of gene expression between untreated and treated samples indicated cellular response to exogenous stimulation. A measurement for the internal fluctuation and instrumental errors was calculated from the untreated samples as described by Dozmorov and Centola 24 and termed 'reference group'. The expression of each gene was compared with the reference group to measure their temporal variations. Genes that had higher variation across time points than the variation observed in the reference group were characterized as HV genes. HV genes whose expression changed over time for 5a-DHT-, 3a-diol-, and EGF-treated LNCaP cells were selected for further analysis.
To perform clustering analysis, data for all three treatments were put together with each gene presented three times, once for every treatment. By doing so, the identical clustering designation of the genes indicated similarity of time-course expression between genes or between different treatments. The clusters were enumerated in the order of their size, with cluster 1 as the largest one. A total of 30 genes were identified as responsive to all three treatments, their cluster designation is listed in Table 2 .
Among all three treatment groups, expressions of several heat shock proteins (HSP; HSPs 27 (X54079), 40 (D49547), 70 (X51757), and 75 (U12595)), heat shock transcription factor 1 (HSF1; M64673), and cell cycle regulators (cyclins B1 (CCNB1; M25753), G1 (CCNG1; U47413), and H (CCNH; U11791)) were identified and partitioned into the two most common clusters, indicating that these genes were similarly regulated by 5a-DHT, 3a-diol, and EGF. These results suggested that 5a-DHT, LNCaP cells were seeded in each well of 96-well plates at a concentration of 2 Â 10 3 cells/well, and subjected to serum deprivation followed by 5a-DHT, 3a-diol, or EGF stimulation. Cell proliferation was determined using XTT assay everyday for a period of 6 days. Data were calculated as absorbance at days following androgens or EGF stimulation divided by the absorbance determined at the day of stimulation, and presented as fold induction in absorbance following the stimulation. A similar temporal change in cell proliferation was selected for microarray analysis.
3a-diol regulated gene expression in LNCaP cells RA Zimmerman et al 3a-diol, and EGF regulate some downstream pathways in a similar fashion. Among 5a-DHT, 3a-diol, and EGF treatments, 3a-diol/EGF, 5a-DHT/EGF, or 3a-diol/5a-DHT pairs each had 23, 21, and 18 genes of common cluster assignments, correspondingly. Several genes' expression patterns including PRKACB (M34181), PRKR1B (M65066), AR (M20132), TP53 (M14694), and SRC (NM_005417) had different clustering designations, specifically to be 4/4/8, 4/4/12, 1/1/11, 3/2/5, and 3/3/13 for their cluster assignments following 3a-diol/ EGF/5a-DHT treatment. This indicates partitioning between 3a-diol/EGF and 5a-DHT treatment, with slightly higher similarity between 3a-diol/EGF pair than between 5a-DHT/EGF or 3a-diol/5a-DHT pair. The existence of different expression patterns among regulatory molecules such as AR, PRKACB, PRKR1B, TP53, and SRC suggested that there are differentially activated regulatory pathways among these three stimuli.
Dynamics of the HV genes
The selected 30 genes were presented in a novel approach to reveal their inter-and intra-cluster relationships. First, the genes were sorted based on their connectivity within each cluster in 3a-diol-treated sample. Then, the same order was kept in both 5a-DHT-and EGF-treated samples. Inter-relationship between genes was estimated by their correlation coefficients and presented in a correlation mosaic. The genes in one cluster were presented consecutively in 3a-diol treatment as a distinct square, and their positive correlation is shown as bright orange-red colors (Figure 2c ). In the other two treatments, due to their change in expression in response to different treatments, the same ordered genes have different cluster identity and different correlation between each other as manifested by their color variation in the correlation mosaic (Figure 2b and d) .
Across all three treatments, the majority of the 30 genes were clustered into two main groups with several minor groups. Comparison of the expression dynamics of the 5a-DHT-and 3a-diol-treated LNCaP cells ( Figure  2b and c) showed that between them, while the gene cluster borders were still maintained, variations in correlation for several genes-such as RBL2 (X74594), DMP1 (AF084530), GRLF1 (M73077), and MAPK3 (X60188)-changed from positive to negative correlations or vice versa. Likewise, the gene cluster borders and correlation mosaic patterns of the 3a-diol-and EGFtreated LNCaP cells were maintained with some changes in gene correlations, such as PRKAR1A (M33336), AR, CCNG1, RB1, and PRKR1B, between these two treatments (Figure 2c and d) . Except for AR and PRKR1B, genes showing strong correlation with other genes in 5a-DHT-and EGF-treated samples also remained strongly correlated in the 3a-diol treatment, while genes of weak correlation with other genes in 5a-DHT-or EGF-treated cells exhibited positive correlation in 3a-diol-treated cells. As shown in the correlation mosaics, both 3a-diol and 5a-DHT androgens and EGF pathways share significant common gene expression patterns while maintaining their own specificity. 3a-Diol resembles EGF more than 5a-DHT. 4 6 8 10 12 14 16 18 20 22 24 26 28 30 Genes 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 Genes 2 4 6 8 10 12 14 16 18 20 22 24 26 28 Table 2 . Colors associated with different ranges of correlation coefficients are shown adjacent to (a).
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Gene network construction
To determine the relationship among the 30 HV genes given in Table 2 whose expressions were commonly regulated by 5a-DHT, 3a-diol, and EGF, the associations of expression among these genes were evaluated using a novel networking method. For every treatment, the 30 genes were tested against each other through testing partial correlation with each other, as described in Materials and method, to establish their true connections. Using Powerpoint graph features, we built a network based on the genes' connections. The protein nodes were arranged similarly to facilitate discrimination. Both positive and negative correlations were revealed on the graph. Although common sets of genes were identified to be regulated by 5a-DHT, 3a-diol, and EGF in LNCaP cells, significant differences existed in ways these genes influence each other (Figures 3-5) . The gene network identified in these treatments fell into two patterns anchored by AR and GRLF1. In 3a-diol-and EGF-treated LNCaP cells, AR and GRLF1 worked collaboratively and interconnected with PRKACA (X07767) and HSP70 (Figures 3 and 4) . In 5a-DHT-treated samples, AR and GRLF1 were not connected by these two intermediate genes, but rather appeared as if they were in different pathways. AR was positively correlated with CCNB1 expression, and was independent of GRLF1 and other intermediate genes like AKT1 (M63167) or DMP1 (AF084530), as found in 3a-diol-or EGF-treated LNCaP cells. Furthermore, expressions of IL-6 (X04602), BAD (U66879), HSF1, and HSP40 were more closely associated with GRLF1 through PRKAR1A expression in response to 5a-DHT stimulation. In contrast, expression of IL-6, BAD, HSF1, and HSP40 was more associated Table 2 . Solid lines represent positive interconnections with an averaged partial correlation coefficient higher than 0.7, dashed lines interconnections with a negative partial correlation coefficient with averaged value lower than 0.7, and gray lines interconnections duplicated in at least two experimental groups. Figure 5 Gene interconnection in response to 5a-DHT. All designations are the same as in Figure 3 .
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with AR expression in 3a-diol-and EGF-treated cells, and had no direct connectivity with PRKAR1A in GRLF1 group. A slight difference of calculated connectivity of genes between 3a-diol and EGF stimulation may reflect the presence of either divergent pathways between these two stimuli or experimental errors. These results suggested that connectivities among the responsive genes were more closely related between 3a-diol and EGF than those between 3a-diol and 5a-DHT.
Differential regulation of gene expression by androgens and EGF
We confirmed temporal regulation of AR, MAPK3, CTNNB1, and RB1 transcript expression by 5a-DHT, 3a-diol, and EGF by RT-PCR analysis. The selected genes represented similar and differential responsive genes following androgens and EGF stimulation as listed in Table 2 . Levels of these genes expression were normalized to levels of b-actin expression at each time point ( Figure 6 ). Temporal changes in these gene expressions confirmed the differential cluster distribution analyzed by bioinformatics.
Discussion
We used statistically robust methods in this study for comparative analysis of the gene expression data. First, using a statistically based normalization method, 24-27 the technical noise represented as the 'reference group' was used as an internal standard for selecting HV genes. Second, clustering of the HV genes was performed utilizing the F-test, and a threshold of 0.85 was used to ensure that the cluster was meaningful. Different clusters of HV genes represented distinct expression patterns of truly responsive genes. Third, F-clustering utilized a parameter, denoted 'connectivity', to reveal the most comprehensive global group dynamics of gene behavior. With the above-mentioned stringent statistical criteria, the selected genes were solely attributed to experimental treatments.
Clustering based on the use of correlation coefficients is useful and can be applied for selection of genes with both similar and opposite behaviors. Genes under common regulatory controls or connected through common intermediate elements could show very high similarity in expression. However, correlation coefficients provide information about gene coexpression and do not necessarily reflect functional interconnection of selected genes. The information about functional interconnection could be obtained from partial correlation coefficients. However, determination of a partial correlation coefficient between two genes with extracted influence of all other genes is not practical, especially with the large data set obtained from arrays. For example, calculation based on the use of inverted covariance matrix cannot be used for genes with highly similar expression behavior, as explained by Toh and Horimoto. 28 Preselection of some genes is necessary. In this report, we selected HV genes for the preprocess of networking. Calculation of partial correlations based on a stepwise examination of contribution of each individual gene was performed. Analysis of the influence of each single gene on the partial correlation coefficient of the examined pair enabled to reveal strong interconnections that were not susceptible to other genes' influences, and helped to identify interconnections that were influenced but not cancelled by such genes. In addition, thresholds for the averaged (0.7) and minimal (0.35) partial correlations were chosen by comparing results from experimental data to results obtained from a simulation experiment. The simulation set was constructed by randomizing experimental gene expression values while maintaining the same mean and s.d. over all time points as the experimental data. The identified thresholds provide rational bases for defining connections among genes and, as such, significantly reduce the number of false-positive connections obtained with previous methods, in which arbitrary thresholds were used.
The application of clustering and gene expression networks to the biology of the prostrate yielded several genes known to play important roles in the regulation of cellular growth and differentiation (see Table 2 ). It is notable that many genes that are similarly expressed, that is, within particular gene expression clusters, are functionally related to one another. Cluster 1, for example, contains various HSPs, protein kinases, and receptors including AR. The stress-induced HSP70 and the HSP40 proteins in this cluster interact with AR [30] [31] [32] and are co-chaperones involved in AR stability.
33 GRLF1, also in cluster 1, associates with the promoter region of the glucocorticoid receptor (GR) gene and acts to repress glucocorticoids-elevated GR transcription. Biochemical analysis suggests that GRLF1 interacts with specific sequence motif 34 and, therefore, may direct androgen-specific responses in the model system described here. In addition, EMS1 restructures actin microfilaments and is known to undergo post-translational modification in carcinoma cells in response to EGF. F-means clustering analysis involves multiple steps, including connectivity assignment, clustering assignment, and subsequent clustering process, starting with the gene that has no connection to the established cluster seeds but has highest connectivity. All genes having connection to the new seed will make up the new cluster. This process continues until all genes are assigned clusters. Using this approach, some genes bearing connectivity to different cluster seeds could belong to different clusters. We chose to use the approach of looking at all genes at every step instead of the regular clustering method approach, where once a gene cluster designation is assigned, it is excluded from further consideration. Our approach reveals all possible interconnections, and enables us to look at the global interactions more easily.
Functional connections for gene products in different clusters have also been described. For example, the protein kinase AKT1, in cluster 1, is a downstream effector in the EGFR pathway 36 and is involved in ARmediated signaling in LNCaP cells. 37 IL-6, in cluster 3, reportedly upregulates AR-induced gene activation in LNCaP cells. 38 Recently, Yang et al 39 confirmed this finding and reported that IL-6 can also inhibit AR transactivation via downregulation of AKT1 in LNCaP cells. We have confirmed differential regulation and utilization of AR and AKT by 5a-DHT and 3a-diol (unpublished results). These data support the hypothesis that multiple ligands bind receptors in prostrate cells and result in the stimulation or repression of inter-related pathways in an attempt to maintain homeostasis in this tissue, or that distinct signaling pathways are activated in distinct prostatic cells. The identification of biologically relevant pathways reported here for this model supports the application of the novel statistical procedures utilized here to array-based data.
AR-mediated pathway is believed to regulate androgen-dependent proliferation in the prostate and PCa cells following 5a-DHT exposure. 3a-Diol is reduced from 5a-DHT by 3a-HSDs and has low affinity toward the AR. Although 3a-diol has long been suspected to play a role in various physiological functions, 17, 40 the mechanism behind 3a-diol-mediated androgenic effects remains unclear. 12 Our connectivity analysis revealed that commonly regulated genes are 'associated' differently between 3a-diol-and 5a-DHTstimulated cells, and suggested that 3a-diol might utilize, in addition to the AR pathway, a separate pathway such as EGFR to stimulate prostate cell proliferation. Therefore, accumulation of 3a-diol in the prostate through the actions of 3a-HSDs 41, 42 and 17b-HSD 42,43 may be partially responsible for the pathogenesis of prostatic diseases. Upregulated expression of 3a-HSD transcripts 41 in primary cultures of prostate cells derived from BPH and PCa and proteins (unpublished results) in BPH and PCa tissue sections may account for 3a-diol accumulation in the diseased gland. It is possible that failure of initial treatment modality and further clinical progression of BPH and PCa may result from augmentation of both 5a-DHT and 3a-diol and imbalance of androgen-metabolizing enzymes in the diseased prostate.
In addition to steroid hormones, it has been widely accepted that polypeptide growth factors, including EGF, are involved in the growth and development of normal and diseased human prostate. Controversies exist between androgen and EGF interaction. It has been reported that 5a-DHT does not change intracellular levels of EGF. 44 Although upregulation in EGFR has been detected when these cells were cultured in the presence of androgens, 45, 46 it has been shown that 5a-DHT-stimulated LNCaP cell proliferation is not inhibited by the addition of anti-EGFR neutralizing monoclonal. This suggests that autocrine activation of EGFR is absent in androgen stimulation. 47 In contrast, it has been reported that treating cultured human PCa cells with a tyrosine kinase inhibitor, RG-13022 (tyrphostin), blocks EGF-induced and androgen-stimulated prostate cell proliferation, suggesting that functional tyrosine kinase pathways are required for androgen-induced prostate cell growth. 48 Our bioinformatics analysis suggested that 5a-DHT-elevated cell proliferation may not be mediated totally via increased EGF synthesis or EGFR activation, since connectivity analysis of 5a-DHT-and EGF-regulated genes supports the presence of separate regulatory pathway(s) activated by 5a-DHT and EGF in LNCaP cells.
Currently, androgen ablative therapy is used for treating BPH and PCa. Antiandrogen treatment for BPH involves the use of the 5a-reductase type 2 inhibitor finasteride. 49 Although finasteride reduces plasma 5a-DHT levels by 90%, it reduces prostatic volume by only 30%, suggesting the existence of other sources of 5a-DHT 49 or other molecules responsible for prostate enlargement. When bicalutamide (antiandrogen) is used as monotherapic agent in patients with nonmetastatic locally advanced PCa, bicalutamide is as effective as castration in disease progression and overall survival. 50 When bicalutamide is used as an adjuvant in conjunction to local standard therapy, including radical prostatectomy, radiotherapy, or watchful waiting at the stage of localized or locally advanced, nonmetastatic PCa, a significant risk reduction of cancer progression and bone metastases is observed. However, disease progression is present in more than 70% of the patients who receive bicalutamide monotherapy 49 and more than 30% of patients who receive combined therapy. 51 These studies suggest that there is a pathway(s) other than AR transactivation responsible for disease progression, or that there are hormonally independent cells in the diseased prostate. In the presence of androgen blockades, the AR is not downregulated, 52, 53 and adrenal androgens, AR, and other steroid receptors may stimulate mitogenic growth factor signaling pathways to mediate cellular proliferation. [54] [55] [56] If 3a-diol truly serves as a 'crosstalk' molecule between androgens and growth factors and utilizes the EGF pathway for mediating prostate cell growth, as suggested in our analysis, current strategies of using 5a-reductase inhibitor and/or AR blockers for BPH and PCa treatment for androgen deprivation therapy need to be modified to provide maximal androgen blockade.
